BioCryst director receives RSU and option grants
BioCryst Pharmaceuticals director Machelle Sanders received new equity awards consisting of restricted stock units and stock options.
Rhea-AI Filing Summary
BioCryst Pharmaceuticals director Machelle Sanders received new equity awards consisting of restricted stock units and stock options. She was granted 15,294 shares of Common Stock as Restricted Stock Units under the company’s Non-Employee Director Compensation Policy, which will vest on the first anniversary of the grant date.
She also received an automatic stock option grant covering 33,540 shares of Common Stock at an exercise price of $8.50 per share, expiring on June 11, 2036. After these awards, she directly holds 45,936 shares of Common Stock. These are compensation-related grants, not open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 48,834 shares
Grant/Award
2 txns
Insider
SANDERS MACHELLE
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Automatic Stock Option Grant | 33,540 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 15,294 | $0.00 | $0.00 |
Holdings After Transaction:
Automatic Stock Option Grant — 33,540 contracts (Direct);
Common Stock — 45,936 shares (Direct)
Footnotes (2)
- F1. Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
- F2. Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.
Key Figures
RSU grant size: 15,294 shares
Option grant size: 33,540 options
Option exercise price: $8.50 per share
+2 more
5 metrics
RSU grant size
15,294 shares
Restricted Stock Units granted to director on June 11, 2026
Option grant size
33,540 options
Automatic Stock Option Grant to director on June 11, 2026
Option exercise price
$8.50 per share
Exercise price for Automatic Stock Option Grant
Option expiration
June 11, 2036
Expiration date of Automatic Stock Option Grant
Shares held after grant
45,936 shares
Total Common Stock directly held after RSU grant
Key Terms
Restricted Stock Units, Non-Employee Director Compensation Policy, Automatic Stock Option Grant, stock options
4 terms
Restricted Stock Units financial
"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Non-Employee Director Compensation Policy financial
"pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended"
Automatic Stock Option Grant financial
"Automatic Stock Option Grant"
stock options financial
"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did BioCryst (BCRX) director Machelle Sanders receive?
Machelle Sanders received 15,294 Restricted Stock Units and an automatic stock option grant for 33,540 shares at an exercise price of $8.50. Both awards were issued under BioCryst’s Non-Employee Director Compensation Policy as routine director compensation.
Are the BioCryst (BCRX) equity awards to Machelle Sanders open-market purchases?
No, the awards are not open-market purchases. They are automatic non-employee director grants of Restricted Stock Units and stock options under BioCryst’s Non-Employee Director Compensation Policy, reflecting compensation rather than discretionary buying or selling in the market.
When do Machelle Sanders’ BioCryst (BCRX) Restricted Stock Units vest?
The 15,294 Restricted Stock Units granted to Machelle Sanders will vest on the first anniversary of the grant date. This one-year vesting schedule is specified in the company’s Non-Employee Director Compensation Policy governing automatic director equity awards.
What are the key terms of Machelle Sanders’ BioCryst (BCRX) stock option grant?
She received 33,540 stock options with an exercise price of $8.50 per share, expiring on June 11, 2036. These options were granted automatically under the Non-Employee Director Compensation Policy as part of her non-cash board compensation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
